1. Newborn Screening of 6 Lysosomal Storage Disorders by Tandem Mass Spectrometry.
- Author
-
Chen Y, Yang Y, Zeng Y, Lin Q, Zhao P, Mao B, Qiu X, Huang T, Xu L, and Zhu W
- Subjects
- Humans, Infant, Newborn, Female, alpha-Galactosidase blood, alpha-Galactosidase analysis, Male, Dried Blood Spot Testing methods, Iduronidase blood, Iduronidase analysis, Galactosylceramidase blood, Sphingomyelin Phosphodiesterase blood, Sphingomyelin Phosphodiesterase analysis, Tandem Mass Spectrometry methods, Neonatal Screening methods, Lysosomal Storage Diseases diagnosis, Lysosomal Storage Diseases blood, alpha-Glucosidases blood, alpha-Glucosidases analysis
- Abstract
This study was designed to screen 6 lysosomal storage diseases (LSDs) in neonates using tandem mass spectrometry (MS/MS), and establish cutoff values for these LSDs with 3000 dried blood spots (DBS) samples. Cutoff values for α-L-iduronidase (IDUA), α-galactosidase (GLA), acid beta glucosidase (ABG), β-galactocerebrosidase (GALC), acid sphingomyelinase (ASM), and acid alpha glucosidase (GAA) were as follows: GLA, > 2.06 μmol/L·h; ABG, > 1.78 μmol/L·h; ASM, > 0.99 μmol/L·h; IDUA, > 1.33 μmol/L·h; GALC, > 0.84 μmol/L·h; and GAA, > 2.06 μmol/L·h. There were 30 positives in initial MS/MS screening test, and 15 samples were still positive with repeat testing. Their parents/guardians were recontacted and DBS samples were collected again for test. Only 1 child showed abnormal GAA enzyme activity after recontacting process, and was diagnosed with Pompe disease after genetic screening. Eventually, cutoff values of 6 specific enzyme activities were established and MS/MS is effective for early LSDs screening., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF